BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14716239)

  • 1. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings.
    Parmar H; Sitoh YY; Ho L
    J Comput Assist Tomogr; 2004; 28(1):93-7. PubMed ID: 14716239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted MRI of maple syrup urine disease encephalopathy.
    Cavalleri F; Berardi A; Burlina AB; Ferrari F; Mavilla L
    Neuroradiology; 2002 Jun; 44(6):499-502. PubMed ID: 12070724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.
    Kilicarslan R; Alkan A; Demirkol D; Toprak H; Sharifov R
    Jpn J Radiol; 2012 Jul; 30(6):522-5. PubMed ID: 22476847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI.
    Ha JS; Kim TK; Eun BL; Lee HS; Lee KY; Seol HY; Cha SH
    Pediatr Radiol; 2004 Feb; 34(2):163-6. PubMed ID: 14504844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
    Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
    Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy.
    Sakai M; Inoue Y; Oba H; Ishiguro A; Sekiguchi K; Tsukune Y; Mitomo M; Nakamura H
    J Comput Assist Tomogr; 2005; 29(4):524-7. PubMed ID: 16012312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema.
    Righini A; Ramenghi LA; Parini R; Triulzi F; Mosca F
    J Neuroimaging; 2003 Apr; 13(2):162-5. PubMed ID: 12722501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural white matter changes in adolescents and young adults with maple syrup urine disease.
    Klee D; Thimm E; Wittsack HJ; Schubert D; Primke R; Pentang G; Schaper J; Mödder U; Antoch A; Wendel U; Cohnen M
    J Inherit Metab Dis; 2013 Nov; 36(6):945-53. PubMed ID: 23355088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants.
    Brismar J; Aqeel A; Brismar G; Coates R; Gascon G; Ozand P
    AJNR Am J Neuroradiol; 1990; 11(6):1219-28. PubMed ID: 2124065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal citrullinemia: comparison of conventional MR, diffusion-weighted, and diffusion tensor findings.
    Majoie CB; Mourmans JM; Akkerman EM; Duran M; Poll-The BT
    AJNR Am J Neuroradiol; 2004 Jan; 25(1):32-5. PubMed ID: 14729525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal maple syrup urine disease case report and literature review.
    Liu Q; Li F; Zhou J; Liu X; Peng J; Gong L
    Medicine (Baltimore); 2022 Dec; 101(50):e32174. PubMed ID: 36550798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis.
    Sato T; Muroya K; Hanakawa J; Asakura Y; Aida N; Tomiyasu M; Tajima G; Hasegawa T; Adachi M
    Pediatr Int; 2014 Feb; 56(1):112-5. PubMed ID: 24548198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maple syrup urine disease: diffusion MRI, and proton MR spectroscopy findings.
    Sener RN
    Comput Med Imaging Graph; 2007 Mar; 31(2):106-10. PubMed ID: 17207604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion magnetic resonance imaging in intermediate form of maple syrup urine disease.
    Sener RN
    J Neuroimaging; 2002 Oct; 12(4):368-70. PubMed ID: 12380485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Findings in Maple Syrup Urine Disease: A Case Report.
    Kathait AS; Puac P; Castillo M
    J Pediatr Neurosci; 2018; 13(1):103-105. PubMed ID: 29899783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of restricted diffusion seen on magnetic resonance imaging in maple syrup urine disease.
    Kar J; Nguyen FN; Moody SB
    Pediatr Neurol; 2013 Dec; 49(6):505-6. PubMed ID: 24080272
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early prediction of the injured regions in neonatal brain with hypoxic-ischemic encephalopathy by diffusion weighted imaging and measuring their apparent diffusion coefficient].
    Cai Q; Xue XD; Fu JH; Liu CL; Xuan Z; Zhang L
    Zhonghua Er Ke Za Zhi; 2011 May; 49(5):351-5. PubMed ID: 21624286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report.
    Majoie CB; Akkerman EM; Blank C; Barth PG; Poll-The BT; den Heeten GJ
    AJNR Am J Neuroradiol; 2002 May; 23(5):813-6. PubMed ID: 12006283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucoencephalopathy with brainstem and spinal cord involvement and high lactate: quantitative magnetic resonance imaging.
    Steenweg ME; Pouwels PJ; Wolf NI; van Wieringen WN; Barkhof F; van der Knaap MS
    Brain; 2011 Nov; 134(Pt 11):3333-41. PubMed ID: 22006980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.